文献速递临床试验与 GCP基础与转化研究

伴或不伴镁补充剂的中性粒细胞减少饮食对急性白血病患者炎症因子及异基因造血干细胞移植结局的影响:一项随机临床试验的研究方案

Effect of neutropenic diet with or without magnesium supplementation on inflammatory factors and outcomes of allogeneic hematopoietic stem cell transplantation in patients with acute leukemia: study protocol for a randomized clinical trial.
PubMed 文献 · Trials · 2025-10-31

这是一项在伊朗德黑兰Taleghani医院开展的随机双盲临床试验方案,计划纳入50例接受异基因造血干细胞移植的急性白血病患者,随机分为中性粒细胞减少饮食联合镁补充剂组(25例)与联合安慰剂组(25例),干预组每日口服420 mg枸橼酸镁或安慰剂,持续3周,评估IL-6、TNF-α、ESR、CRP等炎症因子及移植结局,按意向性治疗原则分析。

要点

  • 研究纳入50例拟行异基因造血干细胞移植的急性白血病患者,随机分为镁补充组与安慰剂组各25例。
  • 干预组给予420 mg枸橼酸镁口服,持续3周,对照组给予安慰剂。
  • 评估指标包括IL-6、TNF-α、ESR、CRP等炎症因子及移植相关临床结局。

核心结论

  • 该方案旨在成为首批在双盲随机对照试验中实施口服镁补充计划的研究之一,评估急性白血病异基因造血干细胞移植患者的炎症标志物和临床结局。

研究设计与样本

  • 随机双盲临床试验,在伊朗德黑兰Taleghani医院开展,纳入50例入住骨髓移植病房且符合入选标准的患者,采用置换区组随机化分为两组(每组25例):中性粒细胞减少饮食联合镁补充剂组与中性粒细胞减少饮食联合安慰剂组。

主要发现

  • 干预组与安慰剂组分别给予420 mg枸橼酸镁或安慰剂,持续3周。
  • 通过知情同意书、一般问卷、三日24小时膳食回顾及实验室检测(包括IL-6、TNF-α、ESR、CRP等炎症因子)进行患者评估。
  • 统计分析将基于意向性治疗原则进行。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The management of transplantation-related complications in acute leukemia patients has become increasingly important at the bedside. Limited clinical investigations have been conducted regarding high-dose oral magnesium supplementation. In this study, the effects of oral magnesium citrate will be investigated. Magnesium's role in preventing adverse transplantation outcomes, including graft-versus-host disease (GVHD), will be examined through its inhibitory effects on inflammatory pathways and cytokine production. METHODS: This randomized, double-blind clinical trial will be conducted at Taleghani Hospital in Tehran, Iran. Fifty patients admitted to the bone marrow transplantation ward will be enrolled based on eligibility criteria. Participants will be randomly allocated using permuted block randomization into two groups (n = 25 each): neutropenic diet with magnesium supplementation or neutropenic diet with placebo. In the intervention and placebo groups, 420 mg of magnesium citrate or placebo will be administered for 3 weeks, respectively. Patient assessment will be conducted using consent forms, general questionnaires, three-day 24-h food recalls, and laboratory tests including inflammatory factors such as Interleukin-6 (IL-6), Tumor necrosis factor-alpha (TNF-α), Erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP). Statistical analysis will be performed based on the intention-to-treat principle. DISCUSSION: This protocol aims to be one of the first to implement an oral magnesium supplementation program in a double-blind randomized controlled trial, assessing both inflammatory markers and clinical outcomes in acute leukemia patients undergoing Allo-HSCT. TRIAL REGISTRATION: Iranian Registry of Clinical Trials. IRCT20240812062726N1. URL of trial registry record: https://irct.behdasht.gov.ir/trial/78589 . Registered on 17 September 2024.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Abdolkarimi MJ, Jowshan MR, Parkhideh S, et al. Effect of neutropenic diet with or without magnesium supplementation on inflammatory factors and outcomes of allogeneic hematopoietic stem cell transplantation in patients with acute leukemia: study protocol for a randomized clinical trial. Trials. 2025. PMID: 41174685. doi:10.1186/s13063-025-09201-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。